BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1782081)

  • 1. Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador).
    Kovacs E; Hajto T; Hostanska K
    Eur J Cancer; 1991; 27(12):1672-6. PubMed ID: 1782081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticarcinogenic and antimetastatic activity of Iscador.
    Kuttan G; Menon LG; Antony S; Kuttan R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
    Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of iscador: a Viscum album preparation.
    Hajto T
    Oncology; 1986; 43 Suppl 1():51-65. PubMed ID: 2433654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.
    Eggenschwiler J; Patrignani A; Wagner U; Rehrauer H; Schlapbach R; Rist L; Ramos MH; Viviani A
    Arzneimittelforschung; 2006 Jun; 56(6A):483-96. PubMed ID: 16927530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.
    von Schoen-Angerer T; Goyert A; Vagedes J; Kiene H; Merckens H; Kienle GS
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):449-52. PubMed ID: 25532007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
    Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
    Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals.
    Salzer G
    Oncology; 1986; 43 Suppl 1():66-70. PubMed ID: 3808576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview on anticancer activities of the Viscum album extract Isorel.
    Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
    Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(9):1157-9. PubMed ID: 9597967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship.
    Zarkovic N; Zarkovic K; Grainca S; Kissel D; Jurin M
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S17-22. PubMed ID: 9179362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients are talking about ... Iscador (mistletoe).
    Decker G
    Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.